{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:45:59Z","timestamp":1790099159427,"version":"4.0.1"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81830119 82174249"],"award-info":[{"award-number":["81830119 82174249"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014137","name":"Shanghai Shenkang Hospital Development Center","doi-asserted-by":"publisher","award":["SHDC2020CR 2049B"],"award-info":[{"award-number":["SHDC2020CR 2049B"]}],"id":[{"id":"10.13039\/501100014137","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010098","name":"Shanghai Association for Science and Technology","doi-asserted-by":"publisher","award":["19401970300 20Y21901700"],"award-info":[{"award-number":["19401970300 20Y21901700"]}],"id":[{"id":"10.13039\/100010098","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Chronic hepatitis B (CHB) and non-alcoholic fatty liver disease (NAFLD) are prevalent in China. According to traditional Chinese medicine (TCM) theory, damp-heat (DH) syndrome is common in chronic liver disease. However, the biological characteristics related to quantitative diagnosis remain to be determined. This study aimed to identify the consistent alterations in the gut microbiota associated with DH syndrome in patients with CHB or NAFLD.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> A total of 405 individuals were recruited, of which 146 were participants who met the consistent TCM diagnosis by three senior TCM physicians and were typical syndromes. All participants were required to provide fresh stool and serum samples. The gut microbiota was assessed by fecal 16S rRNA gene sequencing, and the serum metabolite profiles of participants were quantified by an ultra-performance liquid chromatography coupled to tandem mass spectrometry (UPLC-MS\/MS) system. DH syndrome-related bacteria taxa were identified based on the 146 individuals with typical syndromes and validated in all 405 volunteers.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The results showed that CHB and NAFLD patients with typical TCM DH syndrome had consistently elevated serum total bile acid (TBA) levels. Significant alterations in microbial community were observed according to TCM syndromes identification. A total of 870 microbial operational taxonomic units and 21 serum metabolites showed the same variation trends in both the CHB and NAFLD DH syndrome groups. The functional analysis predicts consistent dysregulation of bile acid metabolism. Five genera (<jats:italic>Agathobacter, Dorea, Lachnospiraceae_NC2004_group, Subdoligranulum,<\/jats:italic> and <jats:italic>unclassified_c__Clostridia<\/jats:italic>) significantly decreased in abundance in patients with DH syndrome. We utilize these five genera combined with TBA to construct a random forest classifier model to predict TCM diagnosis. The diagnostic receiver-operator characteristic (ROC) areas for DH syndrome were 0.818 and 0.791 in internal tenfold cross-validation and the test set based on all 405 individuals, respectively.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> There are common signatures of gut microbiota associated with DH syndrome in patients with different chronic liver diseases. Serum TBA combined with DH-related genera provides a good diagnostic potential for DH syndrome in chronic liver disease.<\/jats:p>","DOI":"10.3389\/fphar.2022.1027628","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T05:13:24Z","timestamp":1668662004000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Distinct common signatures of gut microbiota associated with damp-heat syndrome in patients with different chronic liver diseases"],"prefix":"10.3389","volume":"13","author":[{"given":"Yuqing","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianchun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhao","family":"Xun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaohong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: Pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J. Hepatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ajpath.2010.11.026","article-title":"Bile acids induce inflammatory genes in hepatocytes: A novel mechanism of inflammation during obstructive cholestasis","volume":"178","author":"Allen","year":"2011","journal-title":"Am. J. Pathol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"15367","DOI":"10.1038\/s41598-018-33669-4","article-title":"Yinchenhao decoction alleviates liver fibrosis by regulating bile acid metabolism and TGF-\u03b2\/smad\/ERK signalling pathway","volume":"8","author":"Cai","year":"2018","journal-title":"Sci. Rep."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e90780","DOI":"10.1172\/jci.insight.90780","article-title":"Bile acids initiate cholestatic liver injury by triggering a hepatocyte-specific inflammatory response","volume":"2","author":"Cai","year":"2017","journal-title":"JCI Insight"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","article-title":"Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease","volume":"152","author":"Chavez-Talavera","year":"2017","journal-title":"Gastroenterology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"108246","DOI":"10.1016\/j.jnutbio.2019.108246","article-title":"Inter-correlated gut microbiota and SCFAs changes upon antibiotics exposure links with rapid body-mass gain in weaned piglet model","volume":"74","author":"Che","year":"2019","journal-title":"J. Nutr. Biochem."},{"key":"B7","doi-asserted-by":"publisher","first-page":"793820","DOI":"10.1155\/2013\/793820","article-title":"Similar connotation in chronic Hepatitis B and nonalcoholic Fatty liver patients with dampness-heat syndrome","volume":"2013","author":"Dai","year":"2013","journal-title":"Evid. Based. Complement. Altern. Med."},{"key":"B8","first-page":"163","article-title":"Guidelines for diagnosis and treatment of nonalcoholic fatty liver disease (revised in 2010)","volume":"3","author":"Fan","year":"2010","journal-title":"Chin. J. liver Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","article-title":"Gut microbiota in human metabolic health and disease","volume":"19","author":"Fan","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jceh.2021.08.017","article-title":"A current understanding of bile acids in chronic liver disease","volume":"12","author":"Farooqui","year":"2022","journal-title":"J. Clin. Exp. Hepatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"E112","DOI":"10.3390\/antiox8050112","article-title":"The flavonoid quercetin induces AP-1 activation in FRTL-5 thyroid cells","volume":"8","author":"Giuliani","year":"2019","journal-title":"Antioxidants (Basel)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3969\/j.issn.1674-7380.2015.03.001","article-title":"Guidelines for the prevention and treatment of chronic Hepatitis B_ 2015 Vision","volume":"7","author":"GuiQiang","year":"2015","journal-title":"Chin. J. liver Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"409568","DOI":"10.1155\/2012\/409568","article-title":"Traditional Chinese medicine zheng in the era of evidence-based medicine: A literature analysis","volume":"2012","author":"Jiang","year":"2012","journal-title":"Evid. Based. Complement. Altern. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/aps.2014.169","article-title":"An integrated metabonomic and proteomic study on Kidney-Yin Deficiency Syndrome patients with diabetes mellitus in China","volume":"36","author":"Jiang","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"key":"B15","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1152\/physiolgenomics.00114.2017","article-title":"Gut microbiome may contribute to insulin resistance and systemic inflammation in obese rodents: A meta-analysis","volume":"50","author":"Jiao","year":"2018","journal-title":"Physiol. Genomics"},{"key":"B16","doi-asserted-by":"publisher","first-page":"9395","DOI":"10.1038\/srep09395","article-title":"Integrating clinical indexes into four-diagnostic information contributes to the Traditional Chinese Medicine (TCM) syndrome diagnosis of chronic Hepatitis B","volume":"5","author":"Kang","year":"2015","journal-title":"Sci. Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1053\/j.gastro.2020.11.050","article-title":"Longitudinal changes in fecal calprotectin levels among pregnant women with and without inflammatory bowel disease and their babies","volume":"160","author":"Kim","year":"2021","journal-title":"Gastroenterology"},{"key":"B18","first-page":"6","article-title":"Study on the TCM syndrome distribution of non-alcoholic fatty liver disease based on clinical data","volume":"14","author":"Li","year":"2019","journal-title":"World Chin. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"8846637","DOI":"10.1155\/2020\/8846637","article-title":"Comparative analysis of clinical and medication information between chronic hepatitis B patients with damp heat syndrome and spleen deficiency syndrome","volume":"2020","author":"Liu","year":"2020","journal-title":"Evid. Based. Complement. Altern. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/ajcn\/nqz139","article-title":"Dietary quality and the colonic mucosa-associated gut microbiome in humans","volume":"110","author":"Liu","year":"2019","journal-title":"Am. J. Clin. Nutr."},{"key":"B21","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","article-title":"Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases","volume":"569","author":"Lloyd-Price","year":"2019","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"B23","doi-asserted-by":"publisher","first-page":"6734","DOI":"10.1038\/ncomms7734","article-title":"Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome","volume":"6","author":"Macia","year":"2015","journal-title":"Nat. Commun."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/nature08530","article-title":"Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43","volume":"461","author":"Maslowski","year":"2009","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1021\/acs.jproteome.0c00852","article-title":"Bile acid profiles are distinct among patients with different etiologies of chronic liver disease","volume":"20","author":"Sang","year":"2021","journal-title":"J. Proteome Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"7537","DOI":"10.1128\/AEM.01541-09","article-title":"Introducing mothur: Open-source, platform-independent, community-supported software for describing and comparing microbial communities","volume":"75","author":"Schloss","year":"2009","journal-title":"Appl. Environ. Microbiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.jhep.2017.11.025","article-title":"Role of bile acids in the gut-liver axis","volume":"68","author":"Schneider","year":"2018","journal-title":"J. Hepatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1016\/s0140-6736(18)31865-8","article-title":"Chronic Hepatitis B virus infection","volume":"392","author":"Seto","year":"2018","journal-title":"Lancet"},{"key":"B29","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/ptr.6806","article-title":"Preclinical evidence of Yinchenhao decoction on cholestasis: A systematic review and meta-analysis of animal studies","volume":"35","author":"Shi","year":"2021","journal-title":"Phytother. Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.jhep.2008.07.019","article-title":"The active metabolite of leflunomide, A77 1726, protects rat hepatocytes against bile acid-induced apoptosis","volume":"49","author":"Vrenken","year":"2008","journal-title":"J. Hepatol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/hep.27406","article-title":"The global burden of liver disease: The major impact of China","volume":"60","author":"Wang","year":"2014","journal-title":"Hepatology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1089\/omi.2012.0057","article-title":"Traditional Chinese medicine ZHENG and omics convergence: A systems approach to post-genomics medicine in a global world","volume":"17","author":"Wang","year":"2013","journal-title":"OMICS"},{"key":"B33","doi-asserted-by":"publisher","first-page":"10665","DOI":"10.7150\/thno.43528","article-title":"Rhein modulates host purine metabolism in intestine through gut microbiota and ameliorates experimental colitis","volume":"10","author":"Wu","year":"2020","journal-title":"Theranostics"},{"key":"B34","first-page":"147","volume-title":"Guiding principles for clinical research of new traditional Chinese medicine","author":"Xiaoyu","year":"2002"},{"key":"B35","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.gpb.2019.09.007","article-title":"Antidiabetic effects of gegen qinlian decoction via the gut microbiota are attributable to its key ingredient berberine","volume":"18","author":"Xu","year":"2020","journal-title":"Genomics Proteomics Bioinforma."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1142\/S0192415X11009408","article-title":"Traditional Chinese medicine syndrome distribution in chronic Hepatitis B populations: A systematic review","volume":"39","author":"Zeng","year":"2011","journal-title":"Am. J. Chin. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1002\/hep.23384","article-title":"Contemporary clinical research of traditional Chinese medicines for chronic Hepatitis B in China: An analytical review","volume":"51","author":"Zhang","year":"2010","journal-title":"Hepatology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s11655-016-2253-3","article-title":"Key symptoms selection for two major syndromes diagnosis of Chinese medicine in chronic Hepatitis B","volume":"23","author":"Zhao","year":"2017","journal-title":"Chin. J. Integr. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1021\/acs.jproteome.8b00799","article-title":"A large-scale, multi-center urine biomarkers identification of coronary heart disease in TCM syndrome differentiation","volume":"18","author":"Zhou","year":"2019","journal-title":"J. Proteome Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/hep.31150","article-title":"Epidemiological features of NAFLD from 1999 to 2018 in China","volume":"71","author":"Zhou","year":"2020","journal-title":"Hepatology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1000727","DOI":"10.3389\/fendo.2022.1000727","article-title":"Application of herbs and active ingredients ameliorate non-alcoholic fatty liver disease under the guidance of traditional Chinese medicine","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Endocrinol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1027628\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T05:13:32Z","timestamp":1668662012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1027628\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,17]]},"references-count":41,"alternative-id":["10.3389\/fphar.2022.1027628"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.1027628","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,17]]},"article-number":"1027628"}}